Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer
Liquid biopsies could be valuable tools to monitor breast cancer progression and evolution. Here, the authors investigate genomic profiling of tissue and liquid biopsies in a large cohort of patients with breast cancer during the course of therapy to characterise tumour evolution and acquired mutati...
Main Authors: | Smruthy Sivakumar, Dexter X. Jin, Hanna Tukachinsky, Karthikeyan Murugesan, Kimberly McGregor, Natalie Danziger, Dean Pavlick, Ole Gjoerup, Jeffrey S. Ross, Robert Harmon, Jon Chung, Brennan Decker, Lucas Dennis, Garrett M. Frampton, Luciana Molinero, Steffi Oesterreich, Jeffrey M. Venstrom, Geoffrey R. Oxnard, Priti S. Hegde, Ethan S. Sokol |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-35245-x |
Similar Items
-
Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors
by: Jessica K. Lee, et al.
Published: (2022-12-01) -
Intra-patient stability of tumor mutational burden from tissue biopsies at different time points in advanced cancers
by: Timothy V. Pham, et al.
Published: (2021-10-01) -
Genomic landscape of non‐small‐cell lung cancer with methylthioadenosine phosphorylase (MTAP) deficiency
by: Prashanth Ashok Kumar, et al.
Published: (2023-01-01) -
The secret life of viral entry glycoproteins: moonlighting in immune evasion.
by: Jonathan D Cook, et al.
Published: (2013-01-01) -
Pan-cancer landscape of CD274 (PD-L1) copy number changes in 244 584 patient samples and the correlation with PD-L1 protein expression
by: Meagan Montesion, et al.
Published: (2021-05-01)